Diagnosis Using Integrated Metabolomics And Genomics In Neurodevelopment (IMAGINe)

 
 

Brain injuries in early life are commonly thought to cause many cases of cerebral palsy, but in some children, cerebral palsy-like conditions are caused by genetic or metabolic abnormalities. Advances in genomics and metabolomics now allow us to diagnose these other causes of atypical cerebral palsy, and we believe that doing so will enable us to devise more personalized treatments that improve the outcomes for affected children.

Research theme:
BRIGHT Beginnings: Projects to optimize brain and developmental outcomes

Age range: 
Under 19

Principal Investigators: 
Dr. Jan M. Friedman, University of British Columbia
Dr. Clara van Karnebeek, University of British Columbia


 

Meet our network funding partners

Thank you to our generous funding partners, who make our network's activities possible.